Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in

  News Archive

Regeneron Joins Human Vaccines Project
Thursday, February 11, 2016
Regeneron Pharmaceuticals has announced that it has joined the Human Vaccines Project, a public-private partnership to help discover and develop new vaccines and immunotherapies for infectious diseases and cancer.

Madison Researchers Begin Work on Zika Virus
Thursday, February 11, 2016
Work will start with basic questions about Zika virus infection.

Transgene and ABL Announce the Acquisition
Wednesday, February 10, 2016
Company has announced the acquisition of its production asset in Illkirch by ABL Europe.

VBI, GSK Collaborate
Wednesday, February 10, 2016
VBI Vaccines has entered into a research collaboration with GlaxoSmithKline Biologicals SA (“GSK”) to evaluate VBI’s LPV™ Platform. VBI’s LPV Platform is a proprietary formulation and process that enables the development of vaccines and biologics with improved stability and preserved potency.

Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Tuesday, February 09, 2016
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.

Drug that Activates Innate Immune System Identified
Tuesday, February 09, 2016
Researchers from the institute have identified a drug, which is straightforward to synthesize and to couple to antigens that induce an immune response and may prove useful in the generation of vaccines.

Valvena, GSK Sign New R&D Collaboration
Tuesday, February 09, 2016
Valneva to supply process development services for EB66® -based Influenza vaccines.

RedHill Biopharma, Fraunhofer Institute Launch Collaboration
Tuesday, February 09, 2016
Collaboration to focus on the evaluation of RedHill’s Phase II-stage oncology drug candidate, RP101.

Mersana Therapeutics, Takeda Expand Partnership
Monday, February 08, 2016
Mersana to receive $40 million upfront, $20 million upon IND clearance and up to $20 million in equity investment.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 1785

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos